Stocks-00241.HK-Alibaba Health Information Tec

00241.HK Alibaba Health Information Tec

2.8557 -0.0300 (-1.04%)
Trade
Trade

Alibaba Health Information Tec price

-3.05% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
46.57B
Day’s Range
2.8058
-
2.8757
52W Range
2.5861
-
5.0524
Volume (3M)
38.91M
Price-Earnings Ratio
42.21
Revenue
29.48B
Pinned Post
Edited
eToroTeam
📢 MARKET EVENTS UPDATE 📢 Take note of the market hours adjustments due to King's Birthday in Australia and Tuen Ng Festival, Sacred Heart Of Jesus in Hong Kong on June 9th and 10th, 2024. 🕒 ➡️ King's Birthday - 09/06/2024 👉📊 INDICES $AUS200 🚫 Closed ➡️ King's Birthday, Tuen Ng... Show More
Like CommentShare
2 replies
null
.
Top Discussions
haobinxian
Edited
Watchlist of this week : $00241.HK (Alibaba Health Information Tec) This stock has stopped its downward trend, and there's more volume on the upticks. Both are positive signs. $NVDA (NVIDIA Corporation) $TSLA (Tesla Motors, Inc.) $NSDQ100 $SPX500 $AAPL (Apple) $GOOG (Alphabet) $AMZN (Amazon.com... Show More
Like CommentShare
1 reply
null
.
OlenaL
Dear Copiers & Followers, We're at around +4% 🟩 in the green, and it's the end of the month. We're going strong! 💊📊 𝙃𝙚𝙖𝙡𝙩𝙝𝙏𝙚𝙘𝙝 𝙎𝙖𝙡𝙚𝙨 𝘽𝙤𝙤𝙢, 𝙔𝙚𝙩 𝙉𝙤𝙩 𝙞𝙣 𝙑𝙤𝙡𝙪𝙢𝙚 💊📊 Asia’s healthtech companies like $00241.HK (Alibaba Health Information Tec) and Apollo Hospitals... Show More
Like CommentShare
null
.
jimmus974
Oui
100.00%
Non
100.00%
Like CommentShare
null
.
MKinvestor069
Edited
$9988.HK (Alibaba Group Holding Ltd (Hong Kong)) $BABA (Alibaba-ADR) $00241.HK (Alibaba Health Information Tec) Guten Tag, diese Woche ist für mich besonders der Quartalsbericht von Alibaba relevant. Alibaba veröffentlichte am 16.11.2023 auf der quartalsweisen Finanzkonferenz die Ergebnisse für... Show More Translate
Like CommentShare
null
.
ArnauPuche
🚀 Explore Alibaba Health's Potential 🌡️ $00241.HK (Alibaba Health Information Tec) a subsidiary of Alibaba Group, is catching attention. Despite some ups and downs, it's shown a track record of improving profits year after year, making it an intriguing investment option. 💊 Healthcare Innovation:... Show More
Like CommentShare
null
.
ArnauPuche
📊 Portfolio Update 🚀 I'm thrilled to share some exciting news about our portfolio! 🌟 👥 We now have 8 amazing copiers on board, and I'm incredibly grateful for your trust and support. Thank you, everyone! 📈 In terms of investments, here's what we're focusing on: 1. Alibaba (BABA)... Show More
Like CommentShare
null
.
TayfurSener
Ai / Semiconductors have been pumped, now they will sell off for the next industry to be pumped. Theyre already talking shit about Covid returning or some new pandemic that will be manufactured in time to tamper with the next US elections in mid to late 2024. I'm going to roll the dice and guess... Show More
Like CommentShare
2 replies
null
.
Amicosssss
🇺🇸 PFIZER: FDA approved maternal anti-RSV vaccine to protect newborns from respiratory syncytial virus 🇮🇹 PFIZER: la FDA ha approvato il vaccino anti-RSV materno per la protezione dei neonati dal virus respiratorio sinciziale $PFE (Pfizer) $CVS (CVS Health Corp) $XLV $CAH (Cardinal Health Inc) $TDOC... Show More
Like CommentShare
null
.
TrevorChung
undefined logo
00241.HK
Alibaba Health Information Tec
2.8557
-0.0300 (-1.04%)
Trade

About Alibaba Health Information Tec

Ali Health was founded in Kuala Lumpur in 2015 and is a technology company that owns, develops and markets healthcare mobile apps, omni-channel pharmaceutical and healthcare products and online services to assist doctors, hospitals and patients worldwide. Ali Health’s solutions improve the physician and nurse workflow, streamline administration, reduce costs and enhance patient safety. Ali Health declared its mission to make good health achievable at the fingertips and to facilitate medicine through big data capabilities. In addition to the company’s app, Doctor2U, Ali Health operates an e-commerce marketplace for health services and products under the same name. The group also covers aesthetic medicine, physical examinations, vaccinations, oral health, and more. The company has strategic partnerships with a number of well-known international pharmaceutical companies, including Merck Sharp & Dohme, SANOFI, GlaxoSmithKline, AstraZeneca and Merck. In fiscal 2019, the group reported revenue and gross profit of RMB5,095.9 million and RMB1,331.3 million, representing significant year-on-year growth of 108.6% and 103.9%, respectively. Add this instrument to your watchlist and get the latest updates on 0241.HK price movements.
Di Fan Shen
CEO
1.4K
Employees
1998
Founded
HK
HQ
Show More

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
60
High
Industry 
Avg. 53 
48
Environment
67
Social
56
Governance

People Also Bought